Borja Hernández-Breijo (B Hernández-Breijo)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Disease Activity

Top Venues

Journal of clinical medicine

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Borja Hernández-Breijo, Ioannis Parodis, Marta Novella Navarro, Ana Martínez-Feito, Victoria Navarro-Compán, Mariana Díaz-Almirón, Dora Pascual-Salcedo, Alejandro Balsa, Chamaida Plasencia-Rodríguez
Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis. Journal of clinical medicine 11 (17) (2022)
Luis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, Lidia Ruiz-Llorente, María Chaparro, Ivan Guerra, Marisa Iborra, José Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle García-Sánchez, Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, Isabel Vera, María Dolores Martín-Arranz, Francisco Mesonero, Laura Sempere, Fernando Gomollón-Bel, Joaquín Hinojosa, Sofía Zoullas, Jorge Monserrat Sanz, César Menor-Salván, Melchor Alvarez De Mon, Francisco Javier García-Alonso, Miguel Ángel Ortega, Borja Hernández-Breijo
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity. Biomedicines 10 (3) (2022)
Charlotte Lm Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick Dw Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John Dudley Isaacs
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases. Annals of the rheumatic diseases (2022)
Charlotte Lm Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, Guillaume le Mélédo, Alejandro Balsa, Meghna Jani, Denis Mulleman, Victoria Navarro-Compan, Gertjan Wolbink, John Isaac, Astrid van Tubergen
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider. RMD open 8 (2) (2022)
Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors. Scientific reports 11 (1) (2021)
Tamara Rodríguez-Prieto, Borja Hernández-Breijo, Miguel Ángel Ortega, Rafael Gómez, Javier Sánchez Nieves, Luis G Guijarro
Dendritic Nanotheranostic for the Delivery of Infliximab: A Potential Carrier in Rheumatoid Arthritis Therapy. International journal of molecular sciences 21 (23) (2020)
Borja Hernández-Breijo, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, Ana Martínez-Feito, Andrea Jochems, Eva L Kneepkens, Gerrit J Wolbink, Theo Rispens, Cristina Diego, Dora Pascual-Salcedo, Alejandro Balsa
Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis. Arthritis research & therapy 21 (1) (2019)
Borja Hernández-Breijo, T Jurado, E Rodríguez-Martín, A Martínez-Feito, C Plasencia-Rodríguez, A Balsa, M L Alonso-Pacheco, L M Villar, P Herranz-Pinto, D Pascual-Salcedo
Differential blood cellular profile in patients with moderate-to-severe psoriasis treated with classical systemic therapies: a step forward in personalized medicine. The British journal of dermatology 179 (3) (2018)